1. Home
  2. RDW vs XNCR Comparison

RDW vs XNCR Comparison

Compare RDW & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Redwire Corporation

RDW

Redwire Corporation

HOLD

Current Price

$10.21

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$12.93

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDW
XNCR
Founded
2020
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
RDW
XNCR
Price
$10.21
$12.93
Analyst Decision
Buy
Buy
Analyst Count
7
10
Target Price
$12.67
$22.78
AVG Volume (30 Days)
23.0M
806.0K
Earning Date
03-09-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$296,147,000.00
$150,132,000.00
Revenue This Year
$11.62
$18.68
Revenue Next Year
$41.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
38.16
52 Week Low
$4.87
$6.92
52 Week High
$26.66
$21.00

Technical Indicators

Market Signals
Indicator
RDW
XNCR
Relative Strength Index (RSI) 56.69 36.97
Support Level $9.67 $12.41
Resistance Level $12.46 $15.40
Average True Range (ATR) 1.24 0.80
MACD 0.02 -0.18
Stochastic Oscillator 55.36 20.10

Price Performance

Historical Comparison
RDW
XNCR

About RDW Redwire Corporation

Redwire Corp is engaged in mission-critical space solutions and reliable components for the next-generation space economy. It assists its customers in solving the complex challenges of future space missions and industries. The company's space infrastructure offerings include a broad array of modern products and services, which have been enabling space missions. The company's plan enables it to combine decades of flight heritage with a culture creating new technologies that are the building blocks of space infrastructure for government and commercial customers.

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Share on Social Networks: